Blenrep-Based Regimen Yields PFS Benefit in Relapsed/Refractory Myeloma
CHICAGO -- Progression-free survival (PFS) was significantly higher with belantamab mafodotin (belamaf; Blenrep) combined with pomalidomide (Pomalyst) and dexamethasone (BPd), ...
Read more
